Corcept Therapeutics (CORT) Prepaid Assets (2010 - 2026)
Corcept Therapeutics (CORT) reported Prepaid Assets of $6.4 million for Q1 2026, down 74.34% on a YoY basis from $24.9 million in Q1 2025, and down 10.17% sequentially from $7.1 million in Q4 2025.
Corcept Therapeutics (CORT) Prepaid Assets (2010 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 17 years of Prepaid Assets data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 74.34% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (down 74.34% YoY), and the FY2025 full-year result was $7.1 million, down 67.54% from the prior year.
- Prepaid Assets retreated to $6.4 million in Q1 2026, from $7.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $37.5 million in Q3 2025 to a low of $4.6 million in Q3 2024.
- A 5-year average of $16.1 million and a median of $15.9 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets sank 77.29% in 2024 and surged 718.1% in 2025, its largest moves.
- Tracing CORT's Prepaid Assets over 5 years: stood at $16.4 million in 2022, then tumbled by 64.19% to $5.9 million in 2023, then surged by 271.98% to $21.9 million in 2024, then plunged by 67.54% to $7.1 million in 2025, then fell by 10.17% to $6.4 million in 2026.
- Business Quant data shows CORT's Prepaid Assets at $6.4 million in Q1 2026, $7.1 million in Q4 2025, and $37.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corcept Therapeutics | 10.09 Bn | 9.76 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.38 Mn |
| Dec 31, 2025 | 7.10 Mn |
| Sep 30, 2025 | 37.47 Mn |
| Jun 30, 2025 | 7.47 Mn |
| Mar 31, 2025 | 24.87 Mn |
| Dec 31, 2024 | 21.88 Mn |
| Sep 30, 2024 | 4.58 Mn |
| Jun 30, 2024 | 25.50 Mn |
| Mar 31, 2024 | 18.36 Mn |
| Dec 31, 2023 | 5.88 Mn |
| Sep 30, 2023 | 20.16 Mn |
| Jun 30, 2023 | 15.86 Mn |
| Mar 31, 2023 | 15.87 Mn |
| Dec 31, 2022 | 16.42 Mn |
| Sep 30, 2022 | 20.68 Mn |
| Jun 30, 2022 | 15.36 Mn |
| Mar 31, 2022 | 10.44 Mn |
| Dec 31, 2021 | 10.32 Mn |
| Sep 30, 2021 | 9.07 Mn |
| Jun 30, 2021 | 9.00 Mn |